Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 12093728)

1.

Overexpression of FXYD-3 is involved in the tumorigenesis and development of esophageal squamous cell carcinoma.

Zhu ZL, Yan BY, Zhang Y, Yang YH, Wang MW, Zentgraf H, Zhang XH, Sun XF.

Dis Markers. 2013;35(3):195-202. doi: 10.1155/2013/740201. Epub 2013 Aug 27.

2.

Regulatory mechanisms for glycogenolysis and K+ uptake in brain astrocytes.

DiNuzzo M, Mangia S, Maraviglia B, Giove F.

Neurochem Int. 2013 Nov;63(5):458-64. doi: 10.1016/j.neuint.2013.08.004. Epub 2013 Aug 19. Review.

3.

Expression profiles of branchial FXYD proteins in the brackish medaka Oryzias dancena: a potential saltwater fish model for studies of osmoregulation.

Yang WK, Kang CK, Chang CH, Hsu AD, Lee TH, Hwang PP.

PLoS One. 2013;8(1):e55470. doi: 10.1371/journal.pone.0055470. Epub 2013 Jan 31.

4.

Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.

Moshitzky S, Asher C, Garty H.

J Biol Chem. 2012 Jun 15;287(25):21130-41. doi: 10.1074/jbc.M112.347807. Epub 2012 Apr 25.

5.

Identification of zebrafish Fxyd11a protein that is highly expressed in ion-transporting epithelium of the gill and skin and its possible role in ion homeostasis.

Saito K, Nakamura N, Ito Y, Hoshijima K, Esaki M, Zhao B, Hirose S.

Front Physiol. 2010 Aug 23;1:129. doi: 10.3389/fphys.2010.00129. eCollection 2010.

6.

FXYD proteins stabilize Na,K-ATPase: amplification of specific phosphatidylserine-protein interactions.

Mishra NK, Peleg Y, Cirri E, Belogus T, Lifshitz Y, Voelker DR, Apell HJ, Garty H, Karlish SJ.

J Biol Chem. 2011 Mar 18;286(11):9699-712. doi: 10.1074/jbc.M110.184234. Epub 2011 Jan 12.

7.

FXYD2 and Na,K-ATPase expression in isolated human proximal tubular cells: disturbed upregulation on renal hypomagnesemia?

Cairo ER, Swarts HG, Wilmer MJ, Willems PH, Levtchenko EN, De Pont JJ, Koenderink JB.

J Membr Biol. 2009 Oct;231(2-3):117-24. doi: 10.1007/s00232-009-9210-4. Epub 2009 Oct 29.

8.

Na,K-ATPase activity regulates AMPA receptor turnover through proteasome-mediated proteolysis.

Zhang D, Hou Q, Wang M, Lin A, Jarzylo L, Navis A, Raissi A, Liu F, Man HY.

J Neurosci. 2009 Apr 8;29(14):4498-511. doi: 10.1523/JNEUROSCI.6094-08.2009.

9.

FXYD1, a modulator of Na,K-ATPase activity, facilitates female sexual development by maintaining gonadotrophin-releasing hormone neuronal excitability.

Garcia-Rudaz C, Deng V, Matagne V, Ronnekleiv OK, Bosch M, Han V, Percy AK, Ojeda SR.

J Neuroendocrinol. 2009 Feb;21(2):108-22. doi: 10.1111/j.1365-2826.2008.01812.x.

10.

A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.

Bibert S, Aebischer D, Desgranges F, Roy S, Schaer D, Kharoubi-Hess S, Horisberger JD, Geering K.

Mol Biol Cell. 2009 Feb;20(4):1132-40. doi: 10.1091/mbc.E08-10-0999. Epub 2008 Dec 24.

11.

A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia.

Choudhury K, McQuillin A, Puri V, Pimm J, Datta S, Thirumalai S, Krasucki R, Lawrence J, Bass NJ, Quested D, Crombie C, Fraser G, Walker N, Nadeem H, Johnson S, Curtis D, St Clair D, Gurling HM.

Am J Hum Genet. 2007 Apr;80(4):664-72. Epub 2007 Mar 1.

12.

Cytoplasmic tail of phospholemman interacts with the intracellular loop of the cardiac Na+/Ca2+ exchanger.

Wang J, Zhang XQ, Ahlers BA, Carl LL, Song J, Rothblum LI, Stahl RC, Carey DJ, Cheung JY.

J Biol Chem. 2006 Oct 20;281(42):32004-14. Epub 2006 Aug 18.

13.

Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange.

Tucker AL, Song J, Zhang XQ, Wang J, Ahlers BA, Carl LL, Mounsey JP, Moorman JR, Rothblum LI, Cheung JY.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2199-209. Epub 2006 Jun 2.

14.

Correlation of gene and protein structures in the FXYD family proteins.

Franzin CM, Yu J, Thai K, Choi J, Marassi FM.

J Mol Biol. 2005 Dec 9;354(4):743-50. Epub 2005 Oct 28.

15.

Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes.

Zhang XQ, Moorman JR, Ahlers BA, Carl LL, Lake DE, Song J, Mounsey JP, Tucker AL, Chan YM, Rothblum LI, Stahl RC, Carey DJ, Cheung JY.

J Appl Physiol (1985). 2006 Jan;100(1):212-20. Epub 2005 Sep 29.

16.

FXYD3 (Mat-8), a new regulator of Na,K-ATPase.

Crambert G, Li C, Claeys D, Geering K.

Mol Biol Cell. 2005 May;16(5):2363-71. Epub 2005 Mar 2.

17.

Structural studies of apoptosis and ion transport regulatory proteins in membranes.

Franzin CM, Choi J, Zhai D, Reed JC, Marassi FM.

Magn Reson Chem. 2004 Feb;42(2):172-9.

19.

Expression and characterization of the FXYD ion transport regulators for NMR structural studies in lipid micelles and lipid bilayers.

Crowell KJ, Franzin CM, Koltay A, Lee S, Lucchese AM, Snyder BC, Marassi FM.

Biochim Biophys Acta. 2003 Jan 31;1645(1):15-21.

20.

Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties.

Crambert G, Fuzesi M, Garty H, Karlish S, Geering K.

Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11476-81. Epub 2002 Aug 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk